These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23542759)

  • 1. Extended release quetiapine fumarate and pregnancy.
    Tényi T; Nagy Á; Herold R; Fekete S
    Neuropsychopharmacol Hung; 2013 Mar; 15(1):49-50. PubMed ID: 23542759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Administration of once-daily extended release quetiapine in schizophrenic disorders].
    Bartkó G
    Neuropsychopharmacol Hung; 2007 Dec; 9(4):189-95. PubMed ID: 18510263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term symptomatic remission of schizophrenia with once-daily extended release quetiapine fumarate: post-hoc analysis of data from a randomized withdrawal, placebo-controlled study.
    Peuskens J; Trivedi JK; Brecher M; Miller F;
    Int Clin Psychopharmacol; 2010 May; 25(3):183-7. PubMed ID: 20216222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose loading with extended release quetiapine.
    Chae BJ
    J Clin Pharm Ther; 2010 Aug; 35(4):487-9. PubMed ID: 20831551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of polypharmacotherapy in pregnancy: a prospective outcome in a case.
    Yaris F; Yaris E; Kadioglu M; Ulku C; Kesim M; Kalyoncu NI
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):603-5. PubMed ID: 15093969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine use for the treatment of manic episode during pregnancy.
    Cabuk D; Sayin A; Derinöz O; Biri A
    Arch Womens Ment Health; 2007; 10(5):235-6. PubMed ID: 17676430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned.
    Cutler AJ; Tran-Johnson T; Kalali A; Aström M; Brecher M; Meulien D
    Psychopharmacol Bull; 2010; 43(4):37-69. PubMed ID: 21240151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and tolerability of once-daily extended release quetiapine fumarate in hospitalized patients with acute schizophrenia: a 6-week randomized, double-blind, placebo-controlled study.
    Lindenmayer JP; Brown D; Liu S; Brecher M; Meulien D
    Psychopharmacol Bull; 2008; 41(3):11-35. PubMed ID: 18779774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of quetiapine fumarate extended release in the treatment of Korean patients with acute schizophrenia.
    Lee JG; Lee JI; Kim YT; Kim CE; Kim CY; Yoon JS; Yoo SY; Kim YH
    Hum Psychopharmacol; 2012 Jul; 27(4):403-10. PubMed ID: 22753400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C; Lerner V
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study.
    De Deyn PP; Eriksson H; Svensson H;
    Int J Geriatr Psychiatry; 2012 Mar; 27(3):296-304. PubMed ID: 21538537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study.
    Bortnick B; El-Khalili N; Banov M; Adson D; Datto C; Raines S; Earley W; Eriksson H
    J Affect Disord; 2011 Jan; 128(1-2):83-94. PubMed ID: 20691481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
    Datto C; Berggren L; Patel JB; Eriksson H
    Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
    Riesenberg RA; Baldytcheva I; Datto C
    Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies.
    Meulien D; Huizar K; Brecher M
    Hum Psychopharmacol; 2010 Mar; 25(2):103-15. PubMed ID: 20196185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia.
    Möller HJ; Johnson S; Mateva T; Brecher M; Svensson O; Miller F; Meulien D;
    Int Clin Psychopharmacol; 2008 Mar; 23(2):95-105. PubMed ID: 18301124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression.
    Thase ME; Demyttenaere K; Earley WR; Gustafsson U; Udd M; Eriksson H
    Depress Anxiety; 2012 Jul; 29(7):574-86. PubMed ID: 22753280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release.
    Figueroa C; Brecher M; Hamer-Maansson JE; Winter H
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):199-204. PubMed ID: 18948162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention.
    Agid O; Foussias G; Remington G
    Expert Opin Pharmacother; 2010 Oct; 11(14):2301-17. PubMed ID: 20586707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate.
    Sheehan DV; Locklear J; Svedsäter H; Datto C
    Int Clin Psychopharmacol; 2012 Sep; 27(5):239-48. PubMed ID: 22859063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.